Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPAS1 | Q99814 | 8/20 | 0.38 |
| ▸ | DRD2 | P14416 | 4/20 | 0.34 |
| ▸ | DRD4 | P21917 | 3/20 | 0.34 |
| ▸ | DRD3 | P35462 | 3/20 | 0.34 |
| ▸ | DRD1 | P21728 | 2/20 | 0.34 |
| ▸ | DRD5 | P21918 | 2/20 | 0.34 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15077241 | 0.85 | EPAS1 (0.41) | EPAS1DRD2DRD4DRD3DRD1 | |
| SCHEMBL21620884 | 0.80 | KDM4E (0.42) | DRD2DRD4DRD3DRD1DRD5 | |
| SCHEMBL23166109 | 0.79 | EPAS1 (0.41) | EPAS1DRD2DRD4DRD3DRD1 | |
| SCHEMBL29497734 | 0.78 | KDM4E (0.47) | EPAS1CA1CA2 | |
| SCHEMBL20582859 | 0.78 | KDM4E (0.47) | EPAS1CA1CA2 | |
| SCHEMBL8502379 | 0.78 | EPAS1 (0.47) | EPAS1CA1CA2 | |
| SCHEMBL11696793 | 0.77 | DRD2 (0.33) | DRD2DRD4DRD3DRD1DRD5 | |
| SCHEMBL4462296 | 0.77 | ALDH1A1 (0.35) | EPAS1DRD2DRD4DRD3DRD1 | |
| SCHEMBL12856680 | 0.75 | EPAS1 (0.34) | EPAS1DRD2DRD4DRD3DRD1 | |
| SCHEMBL21313423 | 0.75 | PKM (0.43) | EPAS1DRD2DRD4DRD3DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9938462-B2 | Liquid-crystalline media, components for high-frequency technology, and mesogenic compounds | MERCK PATENT GMBH (DE) | 2018-04-10 | — | — | US | disclosed |
| US-9765259-B2 | Mesogenic compounds, liquid-crystalline media and components for high-frequency technology | MERCK PATENT GMBH (DE) | 2017-09-19 | — | — | US | disclosed |
| US-9765259-B2 | Mesogenic compounds, liquid-crystalline media and components for high-frequency technology | MERCK PATENT GMBH (DE) | 2017-09-19 | — | — | US | disclosed |
| US-9752077-B2 | Liquid-crystalline media, components for high-frequency technology, and mesogenic compounds | MERCK PATENT GMBH (DE) | 2017-09-05 | — | — | US | disclosed |
| US-9605204-B2 | Liquid crystal medium and high frequency components comprising same | MERCK PATENT GMBH (DE) | 2017-03-28 | — | — | US | disclosed |
| US-9523037-B2 | Liquid-crystalline media, components for high-frequency technology, and mesogenic compounds | MERCK PATENT GMBH (DE) | 2016-12-20 | — | — | US | disclosed |
| US-9523037-B2 | Liquid-crystalline media, components for high-frequency technology, and mesogenic compounds | MERCK PATENT GMBH (DE) | 2016-12-20 | — | — | US | disclosed |
| EP-2688979-B1 | MESOGENIC COMPOUNDS, LIQUID CRYSTAL MEDIA AND COMPONENTS FOR HIGH FREQUENCY TECHNOLOGY | MERCK PATENT GMBH (DE) | 2016-12-07 | — | — | EP | disclosed |
| EP-2665797-B1 | LIQUID CRYSTALLINE MEDIA, COMPONENTS FOR HIGH FREQUENCY TECHNOLOGY AND MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2016-11-23 | — | — | EP | disclosed |
| EP-2688980-B1 | MESOGEN COMPOUNDS, LIQUID CRYSTALLINE MEDIA AND COMPONENTS FOR HIGH FREQUENCY TECHNOLOGY | MERCK PATENT GMBH (DE) | 2016-11-02 | — | — | EP | disclosed |
| WO-2014094973-A1 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2014-06-26 | — | — | WO | disclosed |
| US-20140021405-A1 | MESOGENIC COMPOUNDS, LIQUID-CRYSTALLINE MEDIA AND COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY | MERCK PATENT GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| US-20140021405-A1 | MESOGENIC COMPOUNDS, LIQUID-CRYSTALLINE MEDIA AND COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY | MERCK PATENT GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| US-20140021409-A1 | MESOGENIC COMPOUNDS, LIQUID-CRYSTALLINE MEDIA AND COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY | MERCK PATENT GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| US-20140021409-A1 | MESOGENIC COMPOUNDS, LIQUID-CRYSTALLINE MEDIA AND COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY | MERCK PATENT GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| US-20130292608-A1 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2013-11-07 | — | — | US | disclosed |
| US-20130292608-A1 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2013-11-07 | — | — | US | disclosed |
| US-20130221274-A1 | COMPOUNDS FOR A LIQUID-CRYSTALLINE MEDIUM, AND THE USE THEREOF FOR HIGH-FREQUENCY COMPONENTS | MERCK PATENT GMBH (DE) | 2013-08-29 | — | — | US | disclosed |
| US-20130221274-A1 | COMPOUNDS FOR A LIQUID-CRYSTALLINE MEDIUM, AND THE USE THEREOF FOR HIGH-FREQUENCY COMPONENTS | MERCK PATENT GMBH (DE) | 2013-08-29 | — | — | US | disclosed |
| WO-2013091789-A1 | LIQUID CRYSTAL MEDIUM AND HIGH FREQUENCY COMPONENTS COMPRISING SAME | MERCK PATENT GMBH (DE) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130221274-A1 | COMPOUNDS FOR A LIQUID-CRYSTALLINE MEDIUM, AND THE USE THEREOF FOR HIGH-FREQUENCY COMPONENTS | CRY1, WIZ, HCN3 | EPAS1 2946/4885DRD2 1928/4885DRD4 1091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.